Status:
TERMINATED
Automated MEdical Record Driven Implantable CArdioverter-defibrillator Heart Failure Trial (AMERICA-HF)
Lead Sponsor:
Duke University
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose and Objective: Heart failure therapies including beta-blockers, ACE-inhibitors, aldosterone antagonists, implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT...
Eligibility Criteria
Inclusion
- Left Ventricular Ejection Fraction ≤ 35% on transthoracic echocardiogram
- One of the following ICD-9 HF diagnostic codes 398.91, 428.0, 428.1, 428.2x, 428.3x, 428.4x, 428.9
Exclusion
- Pregnancy
- Inability to speak English
- Inability to provide verbal consent
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT01807130
Start Date
September 1 2013
End Date
September 1 2014
Last Update
December 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Health System
Durham, North Carolina, United States, 27710